Literature DB >> 25635583

Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health.

Nina Holland1, Daneida Lizarraga, Karen Huen.   

Abstract

PURPOSE OF REVIEW: Children are more susceptible to exposures in utero and during early childhood that may result in developmental problems and chronic diseases. Novel discoveries in the field of molecular epidemiology that can help explain susceptibility to exposures and disease will be demonstrated using the multifunctional enzyme paraoxonase 1 (PON1) as an example. RECENT
FINDINGS: The broad PON1 variability in humans, partly due to differences in genetics and age, can confer differential susceptibility because this enzyme can detoxify organophosphate pesticides and has antioxidant properties. Epigenetics plays a significant role in the mediation of the effects of environmental exposure on human health and is hypothesized to be a major contributing factor to the early-life origins of adult disease. Studies highlighted in this review demonstrate the relationship of PON1 polymorphisms with microRNA binding in addition to a link between DNA methylation in the transcriptional regulatory region with changes in PON1 enzyme levels. Other important methodologies such as ancestry informative markers and lactonase activity can enhance studies involving PON1.
SUMMARY: This PON1 model demonstrates that integrating genetic and epigenetic factors, as well as other novel methodologies, can improve our understanding of important susceptibility factors linked to pediatric disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25635583      PMCID: PMC4431624          DOI: 10.1097/MOP.0000000000000192

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  64 in total

1.  Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype.

Authors:  V H Brophy; G P Jarvik; R J Richter; L S Rozek; G D Schellenberg; C E Furlong
Journal:  Pharmacogenetics       Date:  2000-07

2.  Haplotype variation and linkage disequilibrium in 313 human genes.

Authors:  J C Stephens; J A Schneider; D A Tanguay; J Choi; T Acharya; S E Stanley; R Jiang; C J Messer; A Chew; J H Han; J Duan; J L Carr; M S Lee; B Koshy; A M Kumar; G Zhang; W R Newell; A Windemuth; C Xu; T S Kalbfleisch; S L Shaner; K Arnold; V Schulz; C M Drysdale; K Nandabalan; R S Judson; G Ruano; G F Vovis
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

Review 3.  Human population structure and genetic association studies.

Authors:  Elad Ziv; Esteban González Burchard
Journal:  Pharmacogenomics       Date:  2003-07       Impact factor: 2.533

4.  A genome-wide association study of bronchodilator response in Latinos implicates rare variants.

Authors:  Katherine A Drake; Dara G Torgerson; Christopher R Gignoux; Joshua M Galanter; Lindsey A Roth; Scott Huntsman; Celeste Eng; Sam S Oh; Sook Wah Yee; Lawrence Lin; Carlos D Bustamante; Andrés Moreno-Estrada; Karla Sandoval; Adam Davis; Luisa N Borrell; Harold J Farber; Rajesh Kumar; Pedro C Avila; Emerita Brigino-Buenaventura; Rocio Chapela; Jean G Ford; Michael A Lenoir; Fred Lurmann; Kelley Meade; Denise Serebrisky; Shannon Thyne; William Rodríguez-Cintrón; Saunak Sen; José R Rodríguez-Santana; Ryan D Hernandez; Kathleen M Giacomini; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2013-08-29       Impact factor: 10.793

Review 5.  DNA methylation and human disease.

Authors:  Keith D Robertson
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

6.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

Authors:  S L Primo-Parmo; R C Sorenson; J Teiber; B N La Du
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

7.  PON1 and neurodevelopment in children from the CHAMACOS study exposed to organophosphate pesticides in utero.

Authors:  Brenda Eskenazi; Karen Huen; Amy Marks; Kim G Harley; Asa Bradman; Dana Boyd Barr; Nina Holland
Journal:  Environ Health Perspect       Date:  2010-12       Impact factor: 9.031

8.  Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms.

Authors:  Karen Huen; Kim Harley; Jordan Brooks; Alan Hubbard; Asa Bradman; Brenda Eskenazi; Nina Holland
Journal:  Environ Health Perspect       Date:  2009-06-09       Impact factor: 9.031

9.  Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells.

Authors:  Madeleine P Ball; Jin Billy Li; Yuan Gao; Je-Hyuk Lee; Emily M LeProust; In-Hyun Park; Bin Xie; George Q Daley; George M Church
Journal:  Nat Biotechnol       Date:  2009-03-29       Impact factor: 54.908

10.  FTO, RNA epigenetics and epilepsy.

Authors:  Joie Rowles; Morgan Wong; Ryan Powers; Mark Olsen
Journal:  Epigenetics       Date:  2012-09-04       Impact factor: 4.528

View more
  8 in total

Review 1.  Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.

Authors:  Samantha J Merwin; Teresa Obis; Yanelli Nunez; Diane B Re
Journal:  Arch Toxicol       Date:  2017-01-09       Impact factor: 5.153

Review 2.  Cholesterol reduction and macrophage function: role of paraoxonases.

Authors:  C Roger White; G M Anantharamaiah
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

Review 3.  The Relationship between Cancer and Paraoxonase 1.

Authors:  Irma Martha Medina-Díaz; Néstor Ponce-Ruíz; Aurora Elizabeth Rojas-García; José Francisco Zambrano-Zargoza; Yael Y Bernal-Hernández; Cyndia Azucena González-Arias; Briscia S Barrón-Vivanco; José Francisco Herrera-Moreno
Journal:  Antioxidants (Basel)       Date:  2022-03-31

4.  PON1 as a model for integration of genetic, epigenetic, and expression data on candidate susceptibility genes.

Authors:  Karen Huen; Paul Yousefi; Kelly Street; Brenda Eskenazi; Nina Holland
Journal:  Environ Epigenet       Date:  2015-09-11

Review 5.  Occupational exposure to pesticides as a possible risk factor for the development of chronic diseases in humans (Review).

Authors:  Silvia Gangemi; Edoardo Miozzi; Michele Teodoro; Giusi Briguglio; Annamaria De Luca; Carmela Alibrando; Irene Polito; Massimo Libra
Journal:  Mol Med Rep       Date:  2016-10-10       Impact factor: 2.952

6.  Insights into the role of paraoxonase 2 in human pathophysiology.

Authors:  Fauzia Parween; Rinkoo Devi Gupta
Journal:  J Biosci       Date:  2022       Impact factor: 1.826

7.  The shared mother-child epigenetic signature of neglect is related to maternal adverse events.

Authors:  Inmaculada León; Silvia Herrero Roldán; María José Rodrigo; Maykel López Rodríguez; Jonah Fisher; Colter Mitchell; Agustín Lage-Castellanos
Journal:  Front Physiol       Date:  2022-08-24       Impact factor: 4.755

8.  A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease.

Authors:  Sara Diels; Bart Cuypers; Asta Tvarijonaviciute; Bruno Derudas; Evelien Van Dijck; An Verrijken; Luc F Van Gaal; Kris Laukens; Philippe Lefebvre; Jose J Ceron; Sven Francque; Wim Vanden Berghe; Wim Van Hul
Journal:  Clin Epigenetics       Date:  2021-08-13       Impact factor: 6.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.